Reaction

Implant Site Swelling reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 946 reports · 4 co-occurring drugs

As of the last recalculation, Implant Site Swelling appears in 946 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL (PRR 513.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Etonogestrel512513.3518.9
Bupivacaine1433.433.5
Baclofen8824.724.7
Testosterone1918.218.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.